Back to top
more

Addus HomeCare (ADUS)

(Real Time Quote from BATS)

$129.53 USD

129.53
34,570

+0.81 (0.63%)

Updated Oct 2, 2024 11:06 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.68%
2Buy17.55%
3Hold9.21%
4Sell4.93%
5Strong Sell2.36%
S&P50010.96%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

3-Hold of 5     3    

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

Value Score A
Growth Score A
Momentum Score A
VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

C Value A Growth A Momentum A VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Top 19% (49 out of 252)

Industry: Medical - Outpatient and Home Healthcare

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Better trading starts here.

Zacks News

Cardinal Health to Pay $44M as Civil Penalty Settlement

by Zacks Equity Research

Cardinal Health Inc. (CAH) announced that it would shell out $44 million as civil penalties for a 2012 administrative settlement with the U.S. Drug Enforcement Agency or DEA.

    Varian to Acquire PerkinElmer's Medical Imaging Business

    by Zacks Equity Research

    Varian Medical Systems, Inc. (VAR) recently announced an agreement to takeover the Medical Imaging business of Waltham, MA-based PerkinElmer, Inc. (PKI) for $276 million.

      DaVita Ties Up With WellHealth, Expands in Southern Nevada

      by Zacks Equity Research

      DaVita HealthCare Partners Inc. (DVA), a leading provider of dialysis services, announced that HealthCare Partners Nevada, a unit within its medical group, has acquired WellHealth Quality Care.

        Fluidigm Unveils High-Throughput Integrated Fluidic Circuit

        by Zacks Equity Research

        Fluidigm Corporation (FLDM), a leading player in the analysis of single cells and industrial application of genomics, recently unveiled a new high-throughput integrated fluidic circuit (HT IFC) to separate single cells during mRNA sequencing analysis.

          WebMD Health (WBMD) Repurchaces 2 Million Common Shares

          by Zacks Equity Research

          WebMD Health Corp. (WBMD) announced that it has completed a tender offer to purchase 2 million shares of its common stock.

            Accuray: Hong Kong Sanatorium to Buy 3 Radixact Systems

            by Zacks Equity Research

            Accuray Incorporated (ARAY) has signed an agreement with Hong Kong Sanatorium & Hospital per which the latter would purchase three Radixact Systems.

              Meridian Bioscience Partners MedCaptain, Expands in China

              by Zacks Equity Research

              Meridian Bioscience, Inc. (VIVO) announced that its Magellan Diagnostics business has signed a distribution agreement with China-based MedCaptain Medical Technology.

                DexCom (DXCM) Gains FDA Approval for G5 Mobile CGM System

                by Zacks Equity Research

                San Diego, CA-based DexCom, Inc. (DXCM), a renowned medical device company, announced the U.S. FDA approval for its G5 Mobile CGM (continuous glucose monitoring) system.

                  IRADIMED (IRMD) MRidium Magnetic MRI Gets FDA Approval

                  by Zacks Equity Research

                  IRADIMED CORPORATION (IRMD) recently announced the receipt of 510(k) clearance for its MRidium 3860+ magnetic MRI compatible IV infusion pump system, which features the Dose Error Reduction System software (DERS).

                    TransEnterix (TRXC) Opens New Surgical Robotics Facility

                    by Zacks Equity Research

                    TransEnterix (TRXC) announced that it would open a new surgical robotics facility in Milan, Italy.

                      Stryker (SYK) to Pay for Rejuvenate and ABG II Modular-Neck

                      by Zacks Equity Research

                      Stryker Corporation (SYK) announced that it has reached an agreement to compensate patients for Rejuvenate and ABG II Modular-Neck surgeries done prior to Dec 19, 2016.

                        Masimo's (MASI) TFA-1 Forehead Sensor Gets FDA Approval

                        by Zacks Equity Research

                        Masimo Corporation (MASI) recently announced that its TFA-1 Single-Patient-Use Adhesive Forehead Sensor has received a 5I0(k) clearance from the U.S. FDA.

                          PharMerica Amends Credit Facility, Ups Borrowing Capacity

                          by Zacks Equity Research

                          PharMerica Corporation (PMC) announced that it has amended its existing credit agreement.

                            Varian Expands in Croatia with Edge Radiosurgery Product

                            by Zacks Equity Research

                            Varian Medical Systems, Inc. (VAR) announced that its flagship product Edge Radiosurgery system is being installed at Croatia-based Radiochirurgia Zagreb Clinic.

                              Pacific Biosciences Terminates SMRT Agreement with Roche

                              by Zacks Equity Research

                              Pacific Biosciences of California, Inc. (PACB), announced that F. Hoffman-La Roche Ltd has chosen to terminate a preexisting development, commercialization and license agreement.

                                St. Jude Medical (STJ): EnSite Precision Gets FDA Clearance

                                by Zacks Equity Research

                                St. Jude Medical Inc. (STJ), a leading global medical device manufacturer, recently announced U.S. FDA approval for the EnSite Precision cardiac mapping system and Advisor FL Circular Mapping Catheter.

                                  Baxter (BAX) to Acquire India-Based Claris Injectables

                                  by Zacks Equity Research

                                  Baxter International Inc. (BAX), a global medical technology company, has signed a definitive agreement to acquire Claris Lifesciences Limited???s subsidiary Claris Injectables Limited for almost $625 million.

                                    St. Jude Medical: Proclaim Elite SCS System Now CE Marked

                                    by Zacks Equity Research

                                    St. Jude Medical Inc. (STJ), a leading global medical device manufacturer recently announced the CE mark approval for the full-body magnetic resonance (MR) conditional labeling of the Proclaim Elite Spinal Cord Stimulation (SCS) System.

                                      Merit Medical Hits 52-Week High: What's Driving the Stock?

                                      by Zacks Equity Research

                                      Share price of South Jordan, Utah-based Merit Medical Systems, Inc. (MMSI) reached a fresh 52-week high of $26.80 on Dec 9, finally closing a tad lower at $26.60.

                                        West Pharma (WST) Hits 52-Week High on Growth Prospects

                                        by Zacks Equity Research

                                        Shares of West Pharmaceutical Services, Inc. (WST) reached a new 52-week high of $84.21 on Friday, Dec 9, 2016.

                                          The Cooper Companies (COO) Beats Q4 Earnings Estimates

                                          by Zacks Equity Research

                                          The Cooper Companies Inc. (COO) reported adjusted earnings of $2.28 in fourth-quarter 2016, surpassing the Zacks Consensus Estimate by 4 cents and improving 14% on a year-over-year basis.

                                            Integer (ITGR) to Co-Develop CCM Therapy with Impulse Dynamics

                                            by Zacks Equity Research

                                            Integer Holdings Corporation (ITGR) announced that it has signed a development agreement with Impulse Dynamics.

                                              Ecolab (ECL) Rewards Shareholders with 6% Dividend Hike

                                              by Zacks Equity Research

                                              Ecolab Inc. (ECL) declared a quarterly cash dividend of 37 cents per share, reflecting a 6% increase from the previous payout.

                                                ABIOMED Impella CP Gets Expanded FDA Approval, Stock Up

                                                by Zacks Equity Research

                                                Danvers, MA-based ABIOMED, Inc. (ABMD), a leading medical product developer, announced the expanded U.S. FDA pre-market approval (PMA) for the usage of Impella CP heart pump.

                                                  Top Ranked Momentum Stocks to Buy for December 8th

                                                  by Zacks Equity Research

                                                  Here are four stocks with Zacks Rank #1 (Strong Buy) and strong momentum characteristics for investors to consider today, December 8th: